137 related articles for article (PubMed ID: 35993333)
1. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
4. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
Front Immunol; 2022; 13():882589. PubMed ID: 35479073
[TBL] [Abstract][Full Text] [Related]
7. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
8. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
10. Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.
Chang Y; Cui M; Fu X; Han L; Zhang L; Li L; Li X; Sun Z; Wu J; Zhang X; Li Z; Nan F; Yan J; Sheng G; Zhang M
Oncol Lett; 2018 Jul; 16(1):1275-1284. PubMed ID: 30061947
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
Yao S; Jin Z; He L; Zhang R; Liu M; Hua Z; Wang Z; Wang Y
Front Oncol; 2021; 11():788056. PubMed ID: 34938663
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H
J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114
[TBL] [Abstract][Full Text] [Related]
13. [Lymphoma-associated hemophagocytic syndrome(LAHS)].
Takahashi N
Nihon Rinsho; 2000 Mar; 58(3):665-8. PubMed ID: 10741143
[TBL] [Abstract][Full Text] [Related]
14. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.
Sano H; Kobayashi R; Tanaka J; Hashino S; Ota S; Torimoto Y; Kakinoki Y; Yamamoto S; Kurosawa M; Hatakeyama N; Haseyama Y; Sakai H; Sato K; Fukuhara T
Br J Haematol; 2014 Jun; 165(6):786-92. PubMed ID: 24606577
[TBL] [Abstract][Full Text] [Related]
15. How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.
Li N; Jiang M; Wu WC; Wei WW; Zou LQ
Front Oncol; 2021; 11():704962. PubMed ID: 34490105
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognostic analysis of lymphoma-associated hemophagocytic syndrome: A report of 139 cases.
Zhang Q; Wang L; Zhou D; Zhu L; Li L; Xie W; Tan Y; Ye X
Oncol Lett; 2023 Jan; 25(1):13. PubMed ID: 36478898
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of lymphocyte function by IFN-γ secretion capability assay in the diagnosis of lymphoma-associated hemophagocytic syndrome.
Hou H; Luo Y; Wang F; Yu J; Li D; Sun Z
Hum Immunol; 2019 Dec; 80(12):1006-1011. PubMed ID: 31540793
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
[TBL] [Abstract][Full Text] [Related]
19. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
20. Profiling and bioinformatics analyses reveal differential circular RNA expression in NK/T-cell lymphoma-associated hemophagocytic syndrome.
Man C; Fan Y; Yin G; Huang J; Wang J; Qiu H
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32856037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
